We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
+11.3%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$52.3B
AUM Growth
+$4.34B
(+9%)
Cap. Flow
-$146M
Cap. Flow
% of AUM
-0.28%
Top 10 Holdings %
Top 10 Hldgs %
26.12%
Holding
2,277
New
427
Increased
521
Reduced
1,052
Closed
79
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IS
ironSource Ltd.
IS
|
+$136M |
| 2 |
Tesla
TSLA
|
+$119M |
| 3 |
Verizon
VZ
|
+$109M |
| 4 |
Home Depot
HD
|
+$101M |
| 5 |
Pfizer
PFE
|
+$88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$247M |
| 2 |
Intel
INTC
|
+$216M |
| 3 |
Ford
F
|
+$145M |
| 4 |
General Motors
GM
|
+$143M |
| 5 |
Micron Technology
MU
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.15% |
| 2 | Healthcare | 14.97% |
| 3 | Financials | 14.22% |
| 4 | Consumer Discretionary | 11.15% |
| 5 | Communication Services | 8.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
Petco
WOOF
$802M
| $247K | ﹤0.01% |
12,480
-915
| -7% | -$20K |
|
|
VXRT
1877
DELISTED
Vaxart
VXRT
| $246K | ﹤0.01% |
+39,240
| New | +$268K |
|
1878
Artivion
AORT
$1.32B
| $244K | ﹤0.01% |
12,000
| – | – |
|
|
BAND
1879
Bandwidth Inc
BAND
$1.65B
| $244K | ﹤0.01% |
+3,400
| New | +$265K |
|
|
IMGN
1880
DELISTED
Immunogen Inc
IMGN
| $244K | ﹤0.01% |
+32,900
| New | +$204K |
|
1881
HealthStream
HSTM
$828M
| $243K | ﹤0.01% |
9,200
| – | – |
|
|
DNMR
1882
DELISTED
Danimer Scientific, Inc.
DNMR
| $242K | ﹤0.01% |
+710
| New | +$391K |
|
1883
New Oriental
EDU
$8.09B
| $238K | ﹤0.01% |
11,325
| – | – |
|
|
ONT
1884
Onterris Inc
ONT
$743M
| $236K | ﹤0.01% |
+3,340
| New | +$231K |
|
1885
Collegium Pharmaceutical
COLL
$1.16B
| $234K | ﹤0.01% |
12,550
-250
| -2% | -$4.87K |
|
1886
Elbit Systems
ESLT
$38.4B
| $234K | ﹤0.01% |
1,350
+100
| +8% | +$15.5K |
|
|
CIR
1887
DELISTED
CIRCOR International, Inc
CIR
| $234K | ﹤0.01% |
8,600
-5,500
| -39% | -$167K |
|
1888
Fulcrum Therapeutics
FULC
$245M
| $233K | ﹤0.01% |
+14,970
| New | +$297K |
|
1889
IMAX
IMAX
$2.56B
| $233K | ﹤0.01% |
+13,060
| New | +$250K |
|
1890
Scansource
SCSC
$1.16B
| $233K | ﹤0.01% |
6,652
-13,950
| -68% | -$492K |
|
|
AQUA
1891
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $233K | ﹤0.01% |
+4,980
| New | +$217K |
|
1892
Pan American Silver
PAAS
$18.3B
| $230K | ﹤0.01% |
9,200
+800
| +10% | +$20.1K |
|
1893
Middlesex Water
MSEX
$1.08B
| $229K | ﹤0.01% |
1,900
| – | – |
|
|
JMIA
1894
Jumia Technologies
JMIA
$741M
| $228K | ﹤0.01% |
20,000
| – | – |
|
1895
Marcus Corp
MCS
$764M
| $227K | ﹤0.01% |
12,700
| – | – |
|
|
LL
1896
DELISTED
LL Flooring Holdings, Inc.
LL
| $227K | ﹤0.01% |
13,296
-23,200
| -64% | -$409K |
|
1897
Codexis
CDXS
$137M
| $225K | ﹤0.01% |
+7,180
| New | +$236K |
|
|
FIRY
1898
Firy Inc
FIRY
$161M
| $224K | ﹤0.01% |
+1,504
| New | +$289K |
|
1899
Interface
TILE
$2.01B
| $224K | ﹤0.01% |
14,024
-47,250
| -77% | -$735K |
|
1900
American Vanguard Corp
AVD
$75.2M
| $223K | ﹤0.01% |
13,617
-8,000
| -37% | -$125K |
|
Similar funds
SCP
Ensign Peak Advisors's Q4 2021 Portfolio in Review
As of Q4 2021, Ensign Peak Advisors held 2,277 positions worth $52.3B, up 9% from $48B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Ensign Peak Advisors's Q4 2021 filing shows 427 new, 521 increased, 1,052 reduced and 79 closed positions. Its largest new stake was ironSource Ltd.: 13,801,563 shares worth $107M. The largest sale was AT&T, an estimated $247M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q4 2021 buy was ironSource Ltd.: 13,801,563 shares worth $107M.
- Ensign Peak Advisors added most to Tesla in Q4 2021, an estimated $119M increase.
- Ensign Peak Advisors's biggest Q4 2021 reduction was AT&T, cutting an estimated $247M.
- Ensign Peak Advisors fully exited Acceleron Pharma in Q4 2021, selling an estimated $21.5M.
- Ensign Peak Advisors's ten largest holdings make up 26% of its $52.3B portfolio in Q4 2021.
- Ensign Peak Advisors opened 427 new positions and closed 79 in Q4 2021.
- Ensign Peak Advisors's portfolio value rose 9% quarter-over-quarter to $52.3B.
Based on Ensign Peak Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.